Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis

Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis

ObjectiveNon-invasive disease indicators are currently limited and need further research due to the increased non-alcoholic fatty liver disease (NAFLD) prevalence worldwide. The serum uric acid-to-high-density lipoprotein cholesterol ratio (UHR) has been recognized as a novel inflammatory and metabo...

Full description

Bibliographic Details
Main Authors:	Yilian Xie, Kai Huang, Xiangyu Zhang, Zhouxiao Wu, Yiyi Wu, Jinguo Chu, Weiliang Kong, Guoqing Qian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Medicine
Subjects:	UHR NAFLD NHANES steatosis vibration controlled transient elastography
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1164096/full

Similar Items

Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes
by: Yilian Xie, et al.
Published: (2022-08-01)

Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
by: Liping Wang, et al.
Published: (2022-05-01)

Association of nonalcoholic fatty liver disease and liver fibrosis detected by transient elastography with serum retinol in American adults
by: Xiaoxian Niu, et al.
Published: (2023-03-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass and Visceral Fat Accumulation
by: Wang Y, et al.
Published: (2024-01-01)

Clinical and Anamnestic Features of Hepatic Steatosis in Children
by: N.Yu. Zavgorodnia, et al.
Published: (2015-11-01)

Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease
by: Xinyi Yang, et al.
Published: (2024-03-01)

Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease
by: Karolina Grąt, et al.
Published: (2020-08-01)

Association between cumulative uric acid to high-density lipoprotein cholesterol ratio and the incidence and progression of chronic kidney disease
by: Peipei Liu, et al.
Published: (2023-12-01)

Associations of phthalates with NAFLD and liver fibrosis: A nationally representative cross-sectional study from NHANES 2017 to 2018
by: Xingying Chen, et al.
Published: (2022-11-01)

Serum uric acid to high‐density lipoprotein ratio as a novel indicator of inflammation is correlated with the presence and severity of metabolic syndrome: A large‐scale study
by: Rana Kolahi Ahari, et al.
Published: (2023-11-01)

Association of family income to poverty ratio and vibration-controlled transient elastography quantified degree of hepatic steatosis in U.S. adolescents
by: Meiling Tang, et al.
Published: (2023-03-01)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
by: Alihan Oral, et al.
Published: (2019-09-01)

Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD
by: Mònica Pons, et al.
Published: (2022-04-01)

Inverse Association between Serum Selenium Level and Severity of Liver Fibrosis: A Cross-Sectional Study
by: Chi-Wei Shih, et al.
Published: (2022-09-01)

Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India
by: Anirban Sinha, et al.
Published: (2023-10-01)

Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
by: Madalina-Gabriela Taru, et al.
Published: (2023-08-01)

Ultra-processed foods and allergic symptoms among children and adults in the United States: A population-based analysis of NHANES 2005–2006
by: Weiliang Kong, et al.
Published: (2022-11-01)

Role of Ultrasound Methods for the Assessment of NAFLD
by: Golo Petzold
Published: (2022-08-01)

Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database
by: Xu Ming Li, et al.
Published: (2024-03-01)

The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients
by: Ahmed El-Ghandour, et al.
Published: (2023-02-01)

Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity
by: Sara De Nucci, et al.
Published: (2022-09-01)

Corrigendum: Associations between serum biomarkers and non-alcoholic liver disease: results of a clinical study of Mediterranean patients with obesity
by: Sara De Nucci, et al.
Published: (2023-05-01)

Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis
by: Fuji Yang, et al.
Published: (2023-07-01)

Higher ultra processed foods intake is associated with low muscle mass in young to middle-aged adults: a cross-sectional NHANES study
by: Weiliang Kong, et al.
Published: (2024-02-01)

Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017–2018
by: Zayd Adnan Razouki, et al.
Published: (2022-07-01)

Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography
by: Mira Florea, et al.
Published: (2021-06-01)

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study
by: María Teresa Julián, et al.
Published: (2023-01-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine
by: Livianna Carrieri, et al.
Published: (2022-05-01)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
by: Tran Thi Khanh Tuong, et al.
Published: (2020-03-01)

Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease
by: Alam MS, et al.
Published: (2021-07-01)

Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
by: Jiaofeng Huang, et al.
Published: (2022-10-01)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
by: Angeliki Papachristodoulou, et al.
Published: (2021-06-01)

The relationship between NAFLD with diet and exercise: Current perspectives
by: Fariba Aghaei
Published: (2022-12-01)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
by: Tieshan Teng, et al.
Published: (2022-07-01)

Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
by: Chiara Spiezia, et al.
Published: (2023-05-01)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
by: Ming-Lun Yeh, et al.
Published: (2023-10-01)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Lynna Alnimer, et al.
Published: (2023-04-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation
by: Marcus J. Lyall, et al.
Published: (2020-02-01)